TORREYPINES THERAPEUTICS
TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States. Its product portfolio includes both candidates from its drug targeting platforms and in-licensed and acquired product candidates. As of August 31, 2010, its pipeline includes three clinical development programs. It also has three other clinical-stage product candidates, for which it is seeking business development partners, and it has four preclinical product candidates it is developing, three of which are based upon its drug-targeting platforms.
TORREYPINES THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2000-04-01
Address:
La Jolla, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
81.26 M USD
Similar Organizations
Cytori Therapeutics
Cytori Therapeutics engages in the development of autologous cell therapies.
Investors List
Gimv
Gimv investment in Series C - TorreyPines Therapeutics
Advent International
Advent International investment in Series C - TorreyPines Therapeutics
NIF Ventures
NIF Ventures investment in Series C - TorreyPines Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - TorreyPines Therapeutics
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - TorreyPines Therapeutics
Sorrento Ventures
Sorrento Ventures investment in Series C - TorreyPines Therapeutics
Alta Partners
Alta Partners investment in Series C - TorreyPines Therapeutics
More informations about "TorreyPines Therapeutics"
TorreyPines Therapeutics - 2025 Company Profile - Tracxn
TorreyPines Therapeutics is an acquired company based in San Diego (United States), founded in 2000 by Rudy Tanzi. It operates as a Small molecule drugs to treat central nervous system …See details»
TorreyPines Therapeutics - Crunchbase Company …
TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States. Its product portfolio includes both …See details»
TorreyPines Therapeutics, Inc. Completes Merger With Axonyx Inc.
Oct 4, 2006 TorreyPines Therapeutics, Inc. is a biopharmaceutical company that discovers and develops small molecule drugs to treat diseases and disorders of the central nervous system. …See details»
Raptor Pharmaceutical Inc. and TorreyPines Therapeutics, Inc
Jul 28, 2009 Management and Organization . Following the closing, the combined company will have offices in Novato, California. Executive management will be as follows: ... . 415-382-1458 …See details»
Axonyx Inc. And TorreyPines Therapeutics, Inc. Announce Merger ...
Jun 8, 2006 TorreyPines Therapeutics, Inc. is a biopharmaceutical company that discovers and develops small molecule drugs to treat diseases and disorders of the central nervous system. …See details»
TorreyPines Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore TorreyPines Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, 13 news, and 10 literature, Drug:NGX-267, Cysteamine Bitartrate, …See details»
TorreyPines Therapeutics - PitchBook
TorreyPines Therapeutics General Information Description. Developer of novel small molecules intended to treat diseases and disorders of the central nervous system. The company …See details»
Torreypines Therapeutics - VentureRadar
" TorreyPines Therapeutics is a clinical stage biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, development and …See details»
Organization | TorreyPines Therapeutics
TorreyPines Therapeutics Report issue. For profit Phase 1 Phase 2. Founded: La Jolla CA United States ... Organization Overview. First Clinical Trial. 2006 NCT00567086. First Marketed Drug. …See details»
Axonyx and TorreyPines agree on merger - Fierce Biotech
Jun 7, 2006 Axonyx and the privately-held TorreyPines Therapeutics have agreed to merge into a single company that will be devoted to finding new therapies for diseases of the central …See details»
TorreyPines Therapeutics, Inc. (TPTX) Strategically Repositions as ...
Sep 25, 2008 TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, …See details»
TorreyPines Therapeutics - Products, Competitors, Financials, …
May 18, 2016 TorreyPines Therapeutics is a biopharmaceutical company that discovers and develops small molecule drugs to treat diseases and disorders of the central nervous system. …See details»
TorreyPines Therapeutics - Funding, Financials, Valuation & Investors
TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States. New. Resources. Advanced Search. Start Free Trial . ... How …See details»
TorreyPines Saved from Liquidation through Merger with Raptor
Jul 28, 2009 Raptor Pharmaceuticals and TorreyPines Therapeutics entered into a definitive merger agreement. Raptor stockholders will own approximately 95% of the combined …See details»
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc ...
Jul 28, 2009 Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc., todayannounced that they have entered into a definitive merger agreement. Uponclosing, the …See details»
Axonyx, TorreyPines Merger Done For CNS Drugs, Listing
Jun 9, 2006 Creating a company focused on eight central nervous system therapeutics, Axonyx Inc. and TorreyPines Therapeutics Inc. signed a definitive merger agreement. The deal gives …See details»
Raptor Pharmaceuticals Corp. And TorreyPines Therapeutics, Inc ...
Raptor Pharmaceuticals Corp. (Raptor or the Company) (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc. (TorreyPines) (Nasdaq: TPTX), today announced that they …See details»
TorreyPines Chooses Consolidation over IPO | Review Editor
In the midst of a tough IPO market, privately held TorreyPines Therapeutics has chosen to enter into what is essentially a reverse merger with publicly traded Axonyx. For TorreyPines, the …See details»
Raptor Pharmaceutical Inc. and TorreyPines Therapeutics, Inc
Sep 29, 2009 Copies of the joint proxy statement/prospectus and Raptor’s and TorreyPines’ filings with the SEC can also be obtained, without charge, by directing a request to Raptor …See details»
TorreyPines Therapeutics Licenses Posiphen(TM), Bisnorcymcerine …
Nov 18, 2008 TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, …See details»